Singapore inflation hits four-year low, below average MAS forecast for 2025

Singapore inflation hits four-year low, below average MAS forecast for 2025


Signage for the Monetary Authority of Singapore is displayed outside the central bank’s headquarters in Singapore, on October 22, 2019. Singapore’s central bank tightened its monetary policy on Thursday, saying the widely forecast move will slow the inflation momentum.

Ore Huiying | Bloomberg | Getty Images

Singapore’s consumer price index grew 0.9% year on year in February, marking its slowest growth in four years, the Department of Statistics said in a release on Monday.

The figure was in line with expectations by economists polled by Reuters, and lower than January’s figure of 1.2%.

Core inflation, which strips out prices of accommodation and private transport, came in at 0.6%, lower than the 0.8% seen in January and the 0.7% expected by the Reuters poll.

Inflation in Singapore has largely been on a downward trend, leading the country’s monetary authority to loosen its monetary policy for the first time since 2020 in January, citing a faster than expected decline in inflation and warning about a growth slowdown.

The Monetary Authority of Singapore forecast headline inflation to average 1.5%–2.5% in 2025, compared to 2.4% in 2024.

MAS also downgraded its forecasts for the core inflation rate in January — which strips out prices of accommodation and private transport — to an average of 1%–2% in 2025, lower than the 1.5%–2.5% projected in its October 2024 monetary policy release.

Singapore’s GDP growth is projected to grow at 1%-3% over 2025, slower than the 4.4% seen in 2024.



Source

Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly’s in trial
World

Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly’s in trial

Novo Nordisk stock fell over 10% Monday after it said its next-generation weight loss drug didn’t meet its primary target. The drug, CagriSema, didn’t achieve its primary endpoint of demonstrating non-inferiority on weight loss when compared to Eli Lilly‘s rival drug tirzepatide after 84 weeks, Novo said in a statement Monday morning. Eli Lilly‘s stock […]

Read More
Sam Altman defends AI resource usage: Water concerns ‘fake,’ and ‘humans use energy too’
World

Sam Altman defends AI resource usage: Water concerns ‘fake,’ and ‘humans use energy too’

OpenAI CEO Sam Altman on Friday defended the resource demands of artificial intelligence, calling concerns about data centers’ water use “fake” and comparing the energy used by AI systems to that of humans. Altman was speaking on the sidelines of the India AI Impact summit in an interview with The Indian Express when he was […]

Read More
CNBC Daily Open: New Trump tariffs are up after U.S. Supreme Court strikes some down
World

CNBC Daily Open: New Trump tariffs are up after U.S. Supreme Court strikes some down

U.S. President Donald Trump speaks during the National Governors Association Evening Dinner and Reception in the East Room of the White House on February 21, 2026 in Washington, DC, U.S. Al Drago | Getty Images News | Getty Images The U.S. Supreme Court on Friday struck down much of President Donald Trump’s “reciprocal” tariffs, which […]

Read More